Dunad Therapeutics

Dunad Therapeutics

Biotechnology Research

Tunable covalent chemistry with a deep understanding of disease biology to develop transformational medicines.

About us

Dunad Therapeutics combines proprietary, tunable covalent chemistry with a deep understanding of disease biology to discover and develop transformational medicines that selectively and durably target disease drivers.

Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
Cambridge
Type
Privately Held
Founded
2020
Specialties
CNS disease, Oncology, Drug Development, and Covalent Chemistry

Locations

Employees at Dunad Therapeutics

Updates

Similar pages

Browse jobs

Funding